Search
AI may help brain cancer patients avoid biopsy
https://www.utsouthwestern.edu/newsroom/articles/year-2020/ai-brain-cancer.html
Brain cancer patients in the coming years may not need to go under the knife to help doctors determine the best treatment for their tumors.
UT Southwestern team wins grand prize in American Heart Association Data Challenge: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/july-aha-pandey.html
A team led by UT Southwestern Medical Center cardiologist Ambarish Pandey, M.D., was awarded the grand prize in the American Heart Association Heart Failure Data Challenge hosted by the American Heart Association and the Association of Black Cardiologists.
Tackling resistance to HIF2 drugs with an RNA-based therapy: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/october-resistance-to-hif2-drugs.html
Expected to be diagnosed in 2% of men and 1% of women in the U.S., kidney cancer has traditionally been one of the most challenging cancers to treat.
UT Southwestern researchers use AI to detect new family of genes in gut bacteria : Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/june-gut-bacteria.html
Using artificial intelligence, UT Southwestern researchers have discovered a new family of sensing genes in enteric bacteria that are linked by structure and probably function, but not genetic sequence.
Fighting intestinal infections with the body's own endocannabinoids: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2020/fighting-intestinal-infections.html
Endocannabinoids, signaling molecules produced in the body that share features with chemicals found in marijuana, can shut down genes needed for some pathogenic intestinal bacteria to colonize, multiply, and cause disease, new research led by UT Southwestern scientists shows.
Patient's satisfaction with doctor could influence decision to have bariatric surgery: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2023/february-bariatric-surgery.html
Patients’ satisfaction with their physicians may influence their decisions to undergo bariatric surgery, according to a multicenter study.
Fighting inflammatory bowel disease at its source: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2020/fighting-ibd.html
New findings on mechanism for intestinal inflammation could offer new targets for treating ulcerative colitis, Crohn’s disease, and other conditions
Common weight-loss drug successfully targets fat that can endanger heart health: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2021/obesity-drug.html
Researchers at UT Southwestern announced successful results of a clinical trial for a commonly prescribed weight-loss drug called liraglutide.
Helen H. Hobbs, M.D., honored for innovation in cardiovascular science: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2026/march-hobbs-innovation-in-cardiovascular-science.html
Helen H. Hobbs, M.D., Professor in the Eugene McDermott Center for Human Growth and Development and of Internal Medicine and Molecular Genetics at UT Southwestern Medical Center, has been named the recipient of the 2026 Valentin Fuster Award for Innovation in Science by the American College of
Study identifies key protein regulating cholesterol release : Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2026/feb-key-protein-cholesterol-release.html
Two UT Southwestern Medical Center researchers have identified a protein that plays a key role in controlling the liver’s release of cholesterol-carrying lipoproteins into the bloodstream, a discovery that could lead to new treatments for atherosclerotic heart disease and fatty liver disease.